Also trades as: 0157.HK (HKSE) · $vol 0M
NBBTF OTC
Natural Beauty Bio-Technology Limited
1W: +0.0%
1M: +0.0%
3M: -18.0%
YTD: -21.9%
1Y: -20.6%
3Y: -39.8%
5Y: -28.6%
$0.05
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$931M
+20.5% ▲
5Y CAGR: +2.1%
Total Liabilities
$457M
+40.6% ▲
5Y CAGR: +14.8%
Shareholders Equity
$474M
+5.9% ▲
5Y CAGR: -5.0%
Cash & Investments
$112M
-3.8% ▼
5Y CAGR: -7.5%
Total Debt
$319M
+50.5% ▲
5Y CAGR: +33.6%
Net Debt
$215M
+124.8% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $188M | $161M | $159M | $117M | $104M |
| Short-Term Investments | $9M | $8M | $8M | $0 | $8M |
| Cash & ST Investments | $197M | $169M | $167M | $117M | $112M |
| Net Receivables | $116M | $76M | $85M | $72M | $127M |
| Inventory | $121M | $99M | $78M | $81M | $95M |
| Other Current Assets | $145K | $3M | $238K | $1M | $8 |
| Total Current Assets | $450M | $365M | $343M | $289M | $354M |
| Property, Plant & Equip. | $417M | $238M | $271M | $274M | $513M |
| Goodwill & Intangibles | $65M | $51M | $25M | $0 | $0 |
| Long-Term Investments | $10M | $229M | $218M | $0 | $32M |
| Other Non-Current Assets | -$29M | -$25M | $12M | $192M | $2M |
| Total Non-Current Assets | $487M | $519M | $540M | $484M | $577M |
| Total Assets | $937M | $884M | $883M | $773M | $931M |
| — Liabilities — | |||||
| Accounts Payable | $15M | $10M | $21M | $26M | $36M |
| Short-Term Debt | $88M | $114M | $168M | $68M | $187M |
| Deferred Revenue | $14M | $17M | $0 | $0 | $15M |
| Other Current Liabilities | $59M | $69M | $88M | $86M | $80M |
| Total Current Liabilities | $238M | $251M | $283M | $188M | $319M |
| Long-Term Debt | $9M | $6M | $3M | $124M | $117M |
| Other Non-Current Liab. | $302K | $0 | $0 | $0 | $8 |
| Total Non-Current Liabilities | $35M | $24M | $25M | $138M | $138M |
| Total Liabilities | $279M | $286M | $308M | $325M | $457M |
| — Equity — | |||||
| Common Stock | $200M | $200M | $200M | $200M | $200M |
| Retained Earnings | $85M | $55M | $39M | -$64M | -$54M |
| Accumulated OCI | $295M | $271M | $264M | $0 | $256M |
| Total Stockholders Equity | $658M | $597M | $575M | $448M | $474M |
| Total Liabilities & Equity | $937M | $884M | $883M | $773M | $931M |
| — Key Metrics — | |||||
| Total Debt | $129M | $143M | $186M | $212M | $319M |
| Net Debt | -$59M | -$17M | $28M | $96M | $215M |
| Total Investments | $18M | $237M | $226M | $0 | $40M |